Search Results - "Lin, Wangchun"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Cost-effectiveness analysis of transarterial chemoembolization combined with lenvatinib as the first-line treatment for advanced hepatocellular carcinoma by He, Ying, Lin, Wangchun, Cai, Zhongjie, Huang, Yufan, You, Maojin, Lei, Meisheng, Chen, Ruijia

    Published in Frontiers in pharmacology (07-09-2023)
    “…Purpose: Results from the LAUNCH trial suggest transarterial chemoembolization (TACE) in combination with lenvatinib is significantly more effective than…”
    Get full text
    Journal Article
  2. 2

    The cost-effectiveness of cemiplimab plus chemotherapy as the first-line treatment for advanced non-small cell lung cancer by Lu, Tingting, Huang, Yufan, Cai, Zhongjie, Lin, Wangchun, Chen, Xiaoxiao, Chen, Ruijia, Hu, Yingying

    Published in Frontiers in pharmacology (26-07-2023)
    “…The EMPOWER-LUNG 3 clinical trial has shown that cemiplimab plus chemotherapy (CCT) significantly extended overall survival (OS) and progression-free survival…”
    Get full text
    Journal Article
  3. 3

    SHCBP1 Is a Prognostic Biomarker Related to the Tumour Immune Microenvironment in Pan-Cancer by Huang, Yufan, You, Maojin, Wu, Qingfeng, Zhu, Wei, Guo, Fei, Lin, Wangchun

    Published in Annals of clinical and laboratory science (01-11-2022)
    “…Shc SH2 domain-binding protein (SHCBP1) is involved in regulating tumour progression in a variety of tumour types. The aim of this study was to analyze the…”
    Get more information
    Journal Article
  4. 4